The court was asked about the issues of parallel imports and re-branding in relation to a pharmaceutical product containing the active ingredient trospium chloride.
Asplin J
[2013] EWHC 3624 (Ch)
Bailii
England and Wales
Intellectual Property
Updated: 26 November 2021; Ref: scu.518329